|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
4.570 +0.130 (+2.928%) | 2025/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | |
| Turnover | 30,598,292 | 13.216% | 27,026,555 | 26,763,016 | 20,577,616 | 15,518,468 |
| Cost of Sales | (23,166,201) | 9.630% | (21,131,234) | (21,061,682) | (16,469,623) | (11,901,219) |
| Gross Profit | 7,432,091 | 26.068% | 5,895,321 | 5,701,334 | 4,107,993 | 3,617,249 |
| 2025/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (64,663) | 991.174% | (5,926) | 11,381 | (45,620) | (38,413) | |
| Profit / (Loss) before Taxation | 1,559,968 | 66.060% | 939,399 | 550,994 | (252,514) | 401,219 | |
| Taxation | (127,954) | 127.421% | (56,263) | (14,485) | (13,427) | (58,539) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 413 | 21.114% | 341 | (856) | 386 | 5,908 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,432,427 | 62.135% | 883,477 | 535,653 | (265,555) | 348,588 | |
| 2025/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | |
| Net Finance Costs / (Income) | (462,240) | -2.080% | (472,061) | (325,755) | (206,023) | (162,966) |
| Depreciation & Amortisation | 57,605 | 7.308% | 53,682 | 63,719 | 60,576 | 39,626 |
| Directors' Emoluments | -- | -- | 32,547 | 22,243 | 27,436 | 26,601 |
| 2025/03 - Final | %Chg (Compare to Final) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/03 - Final | %Chg (Compare to Final) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| EPS (cts) | 8.910 | 41.653% | 6.290 | 3.970 | -1.970 | 2.630 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.077 | 0.019 | 0.031 | 0.076 |
| NBV per share ($) | 1.014 | -- | 0.904 | 1.122 | 1.043 | 1.060 |
| Remarks: | Real time quote last updated: 15/07/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,432,427 |
| %Change | 62.135% |
| EPS / (LPS) | RMB 0.089 |
| NBV Per Share (¥) | RMB 1.014 |